Gestational diabetes is associated with high energy and saturated fat intakes and with low plasma visfatin and adiponectin levels independent of prepregnancy BMI

European Journal of Clinical Nutrition

Volumn 67, Issue 2, 2013, Pages 196-201

  Park, S ^a   Kim, M Y ^b   Baik, S H ^c   Woo, J T ^d   Kwon, Y J ^a   Daily, J W ^a   Park, Y M ^e   Yang, J H ^b   Kim, S H ^b  

^a Hoseo University   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Kyung Hee University Hospital   (South Korea)

^e The Catholic University of Korea   (South Korea)

Author keywords

adipokines; BMI; gestational diabetes; progesterone; prolactin; weight gain

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; CHOLESTEROL; COMPLEMENT FACTOR D; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROGESTERONE; PROLACTIN; RESISTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE; BODY MASS; CALORIC INTAKE; CARBOHYDRATE INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAMILY HISTORY; FAT INTAKE; FEMALE; FETUS RISK; FIBER INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HIGH RISK PREGNANCY; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SECRETORY CAPACITY; LARGE FOR GESTATIONAL AGE; LIPOPROTEIN BLOOD LEVEL; MACROSOMIA; MAJOR CLINICAL STUDY; PANCREAS ISLET CELL FUNCTION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURITY; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; TAURINE INTAKE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; BODY MASS INDEX; DIABETES, GESTATIONAL; DIET; DIETARY FATS; ENERGY INTAKE; FATTY ACIDS; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OVERWEIGHT; PREGNANCY; PROGESTERONE; REFERENCE VALUES; RISK FACTORS; TAURINE; WEIGHT GAIN;

EID: 84873418891     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2012.207     Document Type: Article

References (24)

1. Hedderson MM, Williams MA, Holt VL, Weiss NS, Ferrara A. Body mass index and weight gain prior to pregnancy and risk of gestational diabetes mellitus. Am J Obstet Gynecol 2008; 198: 409 e1-e7.
2. Coustan DR, Nelson C, Carpenter MW, Carr SR, Rotondo L, Widness JA. Maternal age and screening for gestational diabetes: A population based study. Obstet Gynecol 1989; 73: 557-561.
3. Park S, Park JE, Daily JW, Kim SH. Low gestational weight gain improves infant and maternal pregnancy outcomes in overweight and obese Korean women with gestational diabetes. Gynecol Endocrinol 2011; 27: 775-781.
4. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH et al. Diabetes in Asia: Epidemiology, risk factors, and pathophysiology. JAMA 2009; 301: 2129-2140.
5. Volpe L, Di Cianni G, Lencioni C, Cuccuru I, Benzi L, Del Prato S. Gestational diabetes, inflammation, and late vascular disease. J Endocriol Invest 2007; 30: 873-879.
6. Donath MY, Bo? ni-Schnetzler M, Ellingsgaard H, Ehses JA. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. Physiology 2009; 24: 325-331.
7. Saddi-Rosa P, Oliveira DSV, Giuffrida FMA, Reis AF. Visfatin, glucose metabolism and vascular disease: A review of the evidence. Diabetol Metab Syndr 2010; 2: 21.
8. Hirose H, Yamamoto Y, Seino-Yoshihara Y, Kawabe H, Saito I. Serum high-molecularweight Adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. J Atheroscler Thromb 2010; 17: 1201-1211.
9. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144: 769-773.
10. Bra nişteanu DD, Mathieu C. Progesterone in gestational diabetes mellitus: guilty or not guilty? Trends Endocrinol Metab 2003; 14: 54-56.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
12. Committee of Dietary reference intake in Korean Nutrition Society. Dietary reference intake for Koreans. Korean Nutrition Society: Seoul, 2008.
13. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
14. Lee S, Choi S, Kim HJ, Chung YS, Lee KW, Lee HC et al. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci 2006; 21: 695-700.
15. Salmenhaara M, Uusitalo L, Uusitalo U, Kronberg-kippila? C, Sinkko H, Ahonen S et al. Diet and weight gain characteristics of pregnant women with gestational diabetes. Eur J Clin Nutr 2010; 64: 1433-1440.
16. Arumugam R, Horowitz E, Lu J, Collier J, Ronnebaum S, Fleenor D et al. The interplay of prolactin and the glucocorticoids in the regulation of b-cell gene expression, fatty acid oxidation, and glucose-stimulated insulin secretion: Implications for carbohydrate metabolism in pregnancy. Endocrinology 2008; 149: 5401-5414.
17. Park S, Kim DS, Daily JW, Kim SH. Serum prolactin concentrations determine whether they improve or impair b-cell function and insulin sensitivity in diabetic rats. Diabetes Metab Res Rev 2011; 27: 564-574.
18. de Kreutzenberg SV, Ceolotto G, Papparella I, Bortoluzzi A, Semplicini A, Dalla MC et al. Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: Potential biochemical mechanisms. Diabetes 2010; 59: 1006-1015.
19. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007; 450: 712-716.
20. Qiao L, Shao J. SIRT1 regulates adiponectin gene expression through Foxo1-c/enhancer-binding protein a transcriptional complex. J Biol Chem 2006; 281: 39915-39924.
21. Ramachandran D, Roy U, Garg S, Ghosh S, Pathak S, Kolthur-Seetharam U. Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic b-islets. FEBS J 2011; 278: 1167-1174.
22. Revollo JR, Ko? rner A, Mills KF, Satoh A, Wang T, Garten A et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 2007; 6: 363-375.
23. Song Y, Manson JE, Tinker L, Howard BV, Kuller LH, Nathan L et al. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: The Women's Health Initiative Observational Study. Diabetes Care 2007; 30: 1747-1752.
24. Thompson FE, Subar AF. Dietary assessment methodology. In: Coulston AM, Boushey CJ (eds). Nutrition in the Prevention and Treatment of Disease. 2nd edn. Academic Press: San Diego, CA, USA, 2008.